Pingxiang Peoples Hospital

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Osteoporosis2 trials
• Heart failure1 trial
• Obesity1 trial
• Rheumatoid arthritis1 trial

Phase

• Phase 42 trials
• Phase 21 trial
• Phase 31 trial

Status

• Active, not recruiting2 trials
• Recruiting1 trial
• Terminated1 trial

Lead sponsor

• Amgen3 trials
• BeiGene1 trial

Running trials

• Recruiting

  Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  NCT07037459· Phase 3· Amgen· Source

• Active, not recruiting

  A Study for the Evaluation of Efficacy and Safety of Prolia® in Participants With Glucocorticoid-induced Osteoporosis in Mainland China

  NCT06588153· Phase 4· Amgen· Source

• Active, not recruiting

  Evaluation of Efficacy and Safety of Prolia in Subjects of Male Osteoporosis in Mainland China

  NCT06332014· Phase 4· Amgen· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Heart failure1 recruiting
• Obesity1 recruiting

Closed trials

• Terminated

  A Study Investigating the Efficacy and Safety of BGB-45035 Versus Placebo in Adults With Moderate to Severe Active Rheumatoid Arthritis

  NCT07100938· Phase 2· BeiGene· Source